Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: J Pharm Health Serv Res. 2014 May 14;5(2):109–118. doi: 10.1111/jphs.12055

Table 2.

Numbers and proportions of individuals eligible for medication therapy management services across racial and ethnic groups in 2007–2008 according to 2010 eligibility criteria

Analyses Number of
Drugs
Number of Chronic
Conditions
Groups Number
eligible
Number eligible
weighted
Proportion
eligible (%)
Main Analysis* ≥5 ≥3 Whites 2,459 8,644,373 19.53
Blacks 200 674,674 18.06
Hispanics 173 594,712 16.36
Sensitivity Analysis 1 ≥2 ≥2 Whites 2,907 10,299,559 23.27
Blacks 235 811,766 21.73
Hispanics 212 730,942 20.10
Sensitivity Analysis 2* ≥2 ≥3 Whites 2,504 8,807,423 19.90
Blacks 203 687,726 18.41
Hispanics 176 604,857 16.64
Sensitivity Analysis 3 ≥5 ≥2 Whites 2,833 10,025,724 22.65
Blacks 230 792,668 21.22
Hispanics 209 720,797 19.82
Sensitivity Analysis 4 ≥8 ≥2 Whites 2,362 8,359,397 18.89
Blacks 185 631,883 16.92
Hispanics 179 616,011 16.94
Sensitivity Analysis 5 ≥8 ≥3 Whites 2,113 7,442,804 16.81
Blacks 169 568,099 15.21
Hispanics 153 528,172 14.53
*

P<0.05 for the difference between Whites and Hispanics.